Computershare has sold its US-based mortgage services business for $1.13 billion as part of its strategic realignment to cut costs and deliver more to shareholders, it said in an announcement today.
By Charlie Ormond,
Cancer diagnostic company Pacific Edge saw its shares fall heavily today after the FDA announced plans to regulate the company’s flagship bladder cancer treatment Cxbladder.
By Charlie Ormond,
A tough day on the market for Brickworks today, which reported a 54% drop in profits this morning in its latest financial results. Shareholders bolted as rising costs across the board squeezed the company’s margins into dangerous territory.
By Charlie Ormond,
The Star Entertainment Group saw its shares drop heavily today after it completed a $565 million capital raise with institutional investors as the casino operator attempts to shed debt.
By Charlie Ormond,
Pro Medicus, a healthcare informatics company, has signed a $140 million contract with Baylor Scott & White Health, a US not-for-profit organisation, to supply its Visage 7 cloud-based diagnostic imaging platform.
By Charlie Ormond,
Qantas begins a spending campaign to restore customer relations, and signals heightened costs from rising fuel prices in what looks to be an expensive few years for the airline
By Charlie Ormond,
The board of Costa Group, Australia’s largest fruit and vegetable company, has agreed to a revised takeover bid by a consortium led by Paine Schwartz Partners. The deal will be a welcome relief to shareholders concerned about recent poor performance souring the deal.
By Charlie Ormond,
We have a special essay today from our analyst Charlie Ormond. As tech stocks remain a huge force in the Wall St rallies, we explore some of the hopes that the bulls hold for the AI-linked tech and how ’higher for longer’ interest rates could impact that. Read on…
By Charlie Ormond,
Shell has announced today that its Australian arm has been affected by the massive MOVEit cybersecurity breach that occurred in June 2023, affecting thousands of companies and dubbed the largest hack of this year.
By Charlie Ormond,
Myer met its early August guidance for its July 2022–23 financial year with solid earnings growth but experienced a weak start to the 2023–24 financial year as sales fell off in the second half of the year.
By Charlie Ormond,
Investment ideas from the edge of the bell curve.
Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.
All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.
The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988